ICU Nurse In Klamath Falls: ‘We’re Shattered’
Frontline health care workers treating COVID-19 patients have learned to live with an uncertainty they’ve never experienced before.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Frontline health care workers treating COVID-19 patients have learned to live with an uncertainty they’ve never experienced before.
CVS, Walgreens and Consonus Pharmacy set up their first clinics in nursing homes in Oregon on Monday, marking the start of a weeks-long campaign.
The Department of Consumer and Business Services has struck an agreement with health insurance companies in Oregon to continue coverage through June 30 for in-network telehealth visits with providers.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
For the first time since the pandemic began, one of Oregon’s health care regions had patients in all of its intensive care beds for a day.
The university can only enroll several hundred people in a clinical trial, given its timeframe, so it is picking volunteers who are at high risk of severe symptoms and infection.
The vaccine arrived in Oregon and other states on Monday marking the first step in a months-long drive to get people protected against COVID-19.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Though cases are soaring, Oregon has yet to reach a critical shortage of intensive care beds in part because doctors have learned to treat patients early and now have more drugs.
The Oregon Medical Board has taken more than 200 actions against physicians this year but these are the first emergency suspensions.
Gov. Kate Brown, Oregon's two U.S. senators and four U.S. representatives have asked the U.S. Department of Health and Human Services to extend the health insurance enrollment period through Dec. 31.
The institution seeks volunteers for a promising vaccine developed by Oxford University in Britain in collaboration with AstraZeneca, a British pharmaceutical company.